Featuring Adam Friedman, MD, FAAD Dr. Adam Friedman returned for the afternoon product theater to discuss atopic dermatitis (AD) and treatment with Dupixent. Dupixent is a treatment for moderate to severe atopic dermatitis in patients 12 years of age or older whose disease is not adequately controlled with topical prescription therapies. Dr. Friedman reports “atopic …
The use of oral micronutrients may play a role in reducing atopic dermatitis (AD) symptoms, but what about the topical versions? A recent review examined the current evidence on the benefits of using topical vitamins A, B, C, D, and E, and the minerals magnesium, manganese, zinc and iodine. The review found that the use …
Atopic dermatitis (AD) causes intense itching, and patients are often prescribed antihistamines to mitigate those effects. However, the evidence that non-sedating oral antihistamines are effective at controlling the itch is lacking. Sedating antihistamines have more studies that suggest they are useful. The American Academy of Dermatology (AAD) does not recommend the use of antihistamines for …